Hedge Fund - Samsara BioCapital
Verona Pharma Plc (VRNA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $6,908,300 | 1.07% | 347,500 | $14.77 |
| 2 | 2023 - Q3 (2023-09-30) | $5,664,250 | 1.73% | 347,500 | $19.26 |
| 3 | 2023 - Q2 (2023-06-30) | $7,346,150 | 1.28% | 347,500 | $21.33 |
| 4 | 2023 - Q1 (2023-03-31) | $13,955,620 | 2.88% | 695,001 | $21.59 |
| 5 | 2022 - Q4 (2022-12-31) | $18,160,376 | 3.9% | 695,001 | $13.32 |
| 6 | 2022 - Q3 (2022-09-30) | $9,595,000 | 2.23% | 938,890 | $8.43 |
| 7 | 2022 - Q2 (2022-06-30) | $4,656,000 | 1.24% | 1,111,112 | $4.28 |
| 8 | 2022 - Q1 (2022-03-31) | $5,544,000 | 1.39% | 1,111,112 | $5.82 |
| 9 | 2021 - Q4 (2021-12-31) | $7,467,000 | 1.44% | 1,111,112 | $5.11 |
| 10 | 2021 - Q3 (2021-09-30) | $6,089,000 | 0.95% | 1,111,112 | $5.82 |
| 11 | 2021 - Q2 (2021-06-30) | $7,267,000 | 0.89% | 1,111,112 | $6.93 |
| 12 | 2021 - Q1 (2021-03-31) | $9,289,000 | 1.71% | 1,111,112 | $8.30 |
| 13 | 2020 - Q4 (2020-12-31) | $7,778,000 | 0.78% | 1,111,112 | $6.75 |
| 14 | 2020 - Q3 (2020-09-30) | $6,933,000 | 1.93% | 1,111,112 | $6.91 |
| 15 | 2020 - Q2 (2020-06-30) | $203,000 | 0.06% | 43,456 | $4.63 |
The displayed share prices are average quarterly stock market prices.